Adalta

Adalta ROCE

The Return on Capital Employed (ROCE) of Adalta (1AD.AX) as of Oct 16, 2026 is -1,296.92 %. In the previous year, Return on Capital Employed (ROCE) was 745.28 % — a change of -274.02% (lower).

ROCE

-1,296.92 %

YoY

-274.02%

Last updated:

In 2026, Adalta's return on capital employed (ROCE) was -1,296.92 %, a -274.02% increase from the 745.28 % ROCE in the previous year.

The Adalta ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
-127.19 AUD
Jan 1, 2020
-244.50 AUD
Jan 1, 2021
-133.95 AUD
Jan 1, 2022
-144.36 AUD
Jan 1, 2023
-436.68 AUD
Jan 1, 2024
-262.24 AUD
Jan 1, 2025
745.28 AUD
Jan 1, 2026
-1,296.92 AUD
The Adalta ROCE history
YEARROCEYoY
-1,296.92 %-274.02%
745.28 %-384.20%
-262.24 %-39.95%
-436.68 %+202.49%
-144.36 %+7.77%
-133.95 %-45.22%
-244.50 %+92.24%
-127.19 %-11.94%
-144.43 %+133.05%
-61.98 %+244.46%
-17.99 %-90.38%
-187.10 %-74.11%
-722.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adalta Stock analysis

What does Adalta do? Adalta Ltd is a biotechnology company based in Melbourne, Australia, operating within the Health Care sector. The company focuses on discovering, developing, and commercializing protein-based therapeutics, leveraging its i-body platform technology. Adalta has five active development programs spanning from discovery to Phase II clinical trials, targeting applications in inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic designed for the treatment of fibrotic diseases, including lung fibrosis such as Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD), as well as kidney fibrosis, eye fibrosis, and certain cancers. The company also develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology applications. Additionally, Adalta evaluates several CXCR4 i-bodies. The company went public on August 22, 2016, with its ticker listed as 1AD.AX and ISIN AU0000001AD2. Adalta's website is https://adalta.com.au/. Adalta is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Adalta's Return on Capital Employed (ROCE)

Adalta's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Adalta's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Adalta's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Adalta’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Adalta stock

Return on Capital Employed (ROCE) of Adalta is -1,296.92 % in 2026.

Return on Capital Employed (ROCE) of Adalta changed from 745.28 % to -1,296.92 %, representing a -274.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Adalta since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Adalta with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Adalta

All Key Metrics — Adalta